Publications by authors named "Elsa Lestang"

Claim this Profile
C
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: real-world data from the EarlyMIND study.
Gabriel Brisou, Jérôme Paillassa, Sophie Bernard, Olivier Tournilhac, Luc-Matthieu Fornecker, Elsa Lestang

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, Françoise Boyer, Alberto Santagostino, Elsa Lestang

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.
Sophie Vantyghem, Pierre Peterlin, Sylvain Thépot, Audrey Ménard, Viviane Dubruille, Elsa Lestang

Haematologica· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5-positive B-cell neoplasms.
Camille Debord, Nelly Robillard, Olivier Theisen, Thomas Gastinne, Pascal Godmer, Elsa Lestang

Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
Elsa Lestang, Pierre Peterlin, Yannick Le Bris, Viviane Dubruille, Jacques Delaunay

Eur J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of Pim2 kinase stability and expression in transformed human haematopoietic cells.
Kévin Adam, Mireille Lambert, Elsa Lestang, Gabriel Champenois, Isabelle Dusanter-Fourt

Biosci Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Elsa Lestang, Aurelie Caristan, Antoine Néel, Julie Graveleau, Elisabeth Duhamel

Leuk Lymphoma· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
Amandine Le Bourgeois, Elsa Lestang, Thierry Guillaume, Jacques Delaunay, Sameh Ayari

Eur J Haematol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis